{
    "2019-02-01": [
        [
            {
                "time": "2018-01-01",
                "original_text": "Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance",
                "features": {
                    "keywords": [
                        "Roche",
                        "Sales",
                        "Up",
                        "Solid",
                        "New Drugs"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Mylan's Generic Version of Advair Diskus Wins FDA Approval",
                "features": {
                    "keywords": [
                        "Mylan",
                        "Generic",
                        "Advair",
                        "Diskus",
                        "FDA",
                        "Approval"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Gene Therapy: Novartis Under The Microscope With Novel Treatment",
                "features": {
                    "keywords": [
                        "Gene",
                        "Therapy",
                        "Novartis",
                        "Novel",
                        "Treatment"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Roundup",
                        "Q4",
                        "Earnings",
                        "Pipeline",
                        "Updates",
                        "PFE",
                        "RHHBY"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}